Emerging Infectious Diseases (May 2021)

Evaluating Differences in Whole Blood, Serum, and Urine Screening Tests for Zika Virus, Puerto Rico, USA, 2016

  • Asher Y. Rosinger,
  • Samantha M. Olson,
  • Sascha R. Ellington,
  • Janice Perez-Padilla,
  • Regina M. Simeone,
  • Caitlin S. Pedati,
  • Betsy A. Schroeder,
  • Gilberto A. Santiago,
  • Freddy A. Medina,
  • Jorge L. Muñoz-Jordán,
  • Laura E. Adams,
  • Romeo R. Galang,
  • Miguel Valencia-Prado,
  • Sonia Bakkour,
  • Candimar Colón,
  • Mary Goodwin,
  • Dana Meaney-Delman,
  • Jennifer S. Read,
  • Lyle R. Petersen,
  • Denise J. Jamieson,
  • Carmen C. Deseda,
  • Margaret A. Honein,
  • Brenda Rivera-García,
  • Carrie K. Shapiro-Mendoza

DOI
https://doi.org/10.3201/eid2705.203960
Journal volume & issue
Vol. 27, no. 5
pp. 1505 – 1508

Abstract

Read online

We evaluated nucleic acid amplification testing (NAAT) for Zika virus on whole-blood specimens compared with NAAT on serum and urine specimens among asymptomatic pregnant women during the 2015–2016 Puerto Rico Zika outbreak. Using NAAT, more infections were detected in serum and urine than in whole blood specimens.

Keywords